Active-Targeting NIR-II Phototheranostics in Multiple Tumor Models Using Platelet-Camouflaged Nanoprobes (vol 12, pg 55624, 2020)

Xiaorui Geng,Duyang Gao,Dehong Hu,Quanhong Liu,Chengbo Liu,Zhen Yuan,Xuanjun Zhang,Xin Liu,Zonghai Sheng,Xiaobing Wang,Hairong Zheng

DOI: https://doi.org/10.1021/acsami.2c18358

IF: 9.5

2022-01-01

ACS Applied Materials & Interfaces

Abstract:Cancer phototheranostics in the second nearinfrared window (NIR-II, 1000-1700 nm) has recently attracted much attention owing to its high efficacy and good safety compared with that in the first near-infrared window (NIR-I, 650-950 nm). However, the lack of theranostic nanoagents with activetargeting features limits its further application in cancer precision therapies. Herein, we constructed platelet-camouflaged nanoprobes with active-targeting characteristics for NIR-II cancer phototheranostics. The as-prepared biomimetic nanoprobes can not only escape phagocytosis by macrophages but also specifically bind to CD44 on the surface of most cancer cells. We evaluated the active-targeting performance of biomimetic nanoprobes in pancreatic cancer, breast cancer, and glioma mouse models and achieved NIR-II photoacoustic imaging with a high signal-to-background ratio and photothermal treatment with excellent tumor growth inhibition. Our results show the great potential of platelet-camouflaged nanoprobes with NIR-II active-targeting features for cancer precision diagnosis and efficient therapies.